The Abdul Latif Jameel Poverty Action Lab Southeast Asia
Jakarta, Indonesia
NCT Number: NCT04222998
The investigators developed a home-based growth chart that offers a simple and inexpensive way for caregivers to have access to simple health and nutrition information guided by behavioural economics analysis as well as to track their child's linear growth, empowering them to act to improve their child's nutrition. Results from a pilot study conducted in rural Zambia suggest that growth charts installed in homes can increase awareness and reduce early-life growth deficits, particularly among children experiencing growth faltering. The main objective of this study is to assess the impact and cost-effectiveness of growth charts through a cluster-randomized trial in Indonesia. The primary outcome is child height-for-age z-score.
Looking for future studies?
Notify Me9 month–14 month
All sexes
Interventional
Not applicable
Jakarta, Indonesia
The study is divided into two phases. In the first phase, growth chart development activities will be conducted in two villages in each of Manggarai Timur and Trenggalek districts to ensure the chart design is compatible with the local context and chart information is understandable to caregivers. Focus group discussions (FGDs), key informant interviews (KIIs), and door-to-door user testing will be conducted in each village. Results from the FGDs and KIIs will inform a draft growth chart design that will then be user tested in 10 households in each village. Qualitative interviews will be conducted with each household approximately two weeks after chart installation to gather insights on the usability of the growth chart. The chart design will then be finalized for use in the second phase of the study.
In the second phase, 1,480 caregiver-child dyads will be recruited and enrolled in the study as part of a baseline survey. Dyads will be sampled using a two-stage procedure. 110 villages will be selected proportionate to national census population size. All sub-villages ("dusun") within selected villages will be randomly assigned into two groups: 1) Growth chart; and 2) Control. Eligible caregiver-child dyads with children between 9 and 14 months will be selected from each sub-village.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
-Caregivers with a cognitive disability
The growth chart contains simple information of nutritious food, health, and sanitation information at the top and height chart is located at the bottom where caregivers can measure their child's linear growth. Growth charts will be installed in intervention group homes just after the baseline survey.
Households will be visited for baseline surveys.
Households will be revisited after 1 year of grace-period for baseline end line surveys.
The child's height-for-age and weight-for-age will be measured for participating dyads at the time of the baseline and end line surveys.
Time frame: 12 months
Height/length data will be converted to height for age z-score (HAZ) using WHO (World Health Organization) growth standards.
Time frame: 12 months
Child stunting is defined as height for age z-score (HAZ) < -2
Time frame: 12 months
Weight data will be converted to weight for age z-score (WAZ) using WHO growth standards.
Time frame: 12 months
ECD will be evaluated with the Caregiver Reported Early Childhood Development Instruments (CREDI) Long Form which assesses child cognitive, motor, language, and social-emotional development. It provides a global, population-level measure of ECD for children in the 0-3 age range. The long form has about 60 items coded as Yes=1, No=0 and Don't know=8. The CREDI Long Form creates domain-specific developmental scores.
Boston University
Other
Impact of Home-based Growth Charts on Child Linear Growth in Indonesia
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07430826
Body Weight, Body Weight Changes
View Trial DetailsNCT03676751
Child Growth, Child Mortality
Nouna, Burkina Faso
View Trial DetailsNCT03297970
Behavior Problem, Child Growth
Bogotá, Colombia
View Trial DetailsNCT07569172
Allergies, Anemia
Taabo, Côte d’Ivoire
View Trial Details